ACTUATE THERAPEUTICS, INC. (ACTU) Form 8-K — Oct 28, 2026
Actuate Therapeutics closed an underwritten public offering on October 28, 2026, selling 30,985,900 shares plus warrants for 15,492,950 additional shares at a combined unit price of $0.71 (effectively $0.355 per share), with Newbridge Securities as sole book-runner. The offering generated approximately $9.96 million in net proceeds after underwriting discounts and expenses, and the underwriter holds a 45-day over-allotment option for up to 4,647,885 additional shares and 2,323,942 additional warrants, plus warrants covering 3.5% of shares sold as compensation. Common Warrants carry a $0.45 exercise price and a five-year term, adding substantial potential dilution on top of the new shares.
Key figures
- Gross Proceeds
- approximately $9.96 million net proceeds
- Offering Price
- $0.71 per unit of two shares plus one warrant ($0.355 per share)
- Shares Offered
- 30985900
- Warrant shares
- 15492950
- Company lockup period
- 120 days
- Over allotment shares
- 4647885
- Warrant exercise price
- $0.45
- Underwriter warrant coverage
- 3.5% of shares sold
- Over allotment warrant shares
- 2323942
- Underwriter warrant exercise price
- $0.44375
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.